FDA Recalls Sodium Bicarbonate Injection Vials for Glass Breakage Risk
Exela Pharma Sciences is recalling Sodium Bicarbonate Injection vials due to defective containers that may break and release glass fragments when pressurized during preparation. The recall affects 37,320 vials distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is classified as FDA Class I, which per rubric guidance requires a minimum score of 4. The defective containers pose a risk of glass breakage and release during preparation, though no injuries have been reported in the source text.
Plain-English summary
Exela Pharma Sciences LLC is recalling 8.4% Sodium Bicarbonate Injection, USP (50 mEq/50 mL single-dose vials) due to defective containers. The affected lot is P0001490 with an expiration date of 12/2023. A total of 37,320 vials were distributed nationwide.
The vials have defective containers that can break and release glass fragments when pressurized during preparation for administration. The FDA has received complaints of vial breakage and glass flying when the product is pressurized while being prepared for use.
Healthcare providers who have this product should not administer it and should return it to their supplier or dispose of it safely.
The recalled product
- Product
- 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx Only, Mfd for: Civica, Inc. Lehi, Utah 84043, Mfd by: Exela Pharma Sciences, LLC, Lenoir, NC 28645, Carton NDC 72572-740-20, vial NDC 72572-740-1.
- Manufacturer
- Exela Pharma Sciences LLC
- Category
- Drug
- Hazard
- glass-shards
- defective-container
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: P0001490 Exp. 12/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27